Vertex sues U.S. government over access to fertility support services for Casgevy patients

One of the makers of Casgevy — the world’s first CRISPR-based medicine — filed a lawsuit Monday intended to clear the way for the company to pay for fertility preservation services and treatment for people receiving the therapy, which can interfere with reproduction.